{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:41:47Z","timestamp":1784263307945,"version":"3.55.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1097\/ftd.0000000000000256","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T07:37:08Z","timestamp":1445499428000},"page":"246-252","source":"Crossref","is-referenced-by-count":22,"title":["Development and Validation of a Simple and Rapid UPLC\u2013MS Assay for Valproic Acid and Its Comparison With Immunoassay and HPLC Methods"],"prefix":"10.1097","volume":"38","author":[{"given":"Mingming","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210129","first-page":"385","article-title":"On the propyl derivatives and decomposition of ethylaceto-acetate.","volume":"3","author":"Burton","year":"1882","journal-title":"Am Chem J"},{"key":"R2-8-20210129","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"issue":"suppl 2","key":"R3-8-20210129","first-page":"5","article-title":"The history of valproate in clinical neuroscience.","volume":"37","author":"Henry","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"R4-8-20210129","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0140-6736(05)67098-5","article-title":". Depletion of latent HIV-1 infection in vivo: a proof-of-concept study.","volume":"366","author":"Lehrman","year":"2005","journal-title":"Lancet"},{"key":"R5-8-20210129","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.2174\/0929867023369763","article-title":". Valproate and valproate-analogues: potent tools to fight against cancer.","volume":"9","author":"Blaheta","year":"2002","journal-title":"Curr Med Chem"},{"key":"R6-8-20210129","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0169-409X(02)00153-9","article-title":". Mood stabilizers in Alzheimers disease: symptomatic and neuroprotective rationales.","volume":"54","author":"Tariot","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"R7-8-20210129","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.yebeh.2005.04.010","article-title":"The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview.","volume":"7","author":"Ferraro","year":"2005","journal-title":"Epilepsy Behav"},{"key":"R8-8-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00003088-200746040-00001","article-title":"The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications.","volume":"46","author":"Klotz","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"R9-8-20210129","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0009-9120(83)90042-5","article-title":"Enzyme immunoassay of valproic acid using the Abbott ABA-200 analyzer.","volume":"16","author":"Higgins","year":"1983","journal-title":"Clin Biochem"},{"key":"R10-8-20210129","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/clinchem\/31.1.156","article-title":"Fluorescence polarization immunoassay and enzyme immunoassay compared for free valproic acid in serum ultrafiltrates from epileptic patients.","volume":"31","author":"Haidukewych","year":"1985","journal-title":"Clin Chem"},{"key":"R11-8-20210129","doi-asserted-by":"crossref","first-page":"514","DOI":"10.18097\/pbmc20135905514","article-title":". Modified HPLC method of determination of the valproic acid in biological fluids.","volume":"59","author":"Dutov","year":"2013","journal-title":"Biomed Khim"},{"key":"R12-8-20210129","first-page":"378","article-title":". HPLC determination of valproic acid in human serum.","volume":"58","author":"Kishore","year":"2003","journal-title":"Pharmazie"},{"key":"R13-8-20210129","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0378-4347(94)00129-4","article-title":"Sensitive capillary gas chromatographic-mass spectrometric method for the therapeutic drug monitoring of valproic acid and seven of its metabolites in human serum. Application of the assay for a group of pediatric epileptics.","volume":"656","author":"Darius","year":"1994","journal-title":"J Chromatogr B Biomed Appl"},{"key":"R14-8-20210129","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0378-4347(00)80644-1","article-title":"Capillary gas chromatographic assay for valproic acid and its 2-desaturated metabolite in brain and plasma.","volume":"432","author":"Semmes","year":"1988","journal-title":"J Chromatogr"},{"key":"R15-8-20210129","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.talanta.2006.09.033","article-title":". A high throughput and selective method for the estimation of valproic acid an antiepileptic drug in human plasma by tandem LC-MSMS.","volume":"72","author":"Jain","year":"2007","journal-title":"Talanta"},{"key":"R16-8-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/bmc.944","article-title":". A simple and rapid determination of valproic acid in human plasma using a non-porous silica column and liquid chromatography with tandem mass spectrometric detection.","volume":"22","author":"Matsuura","year":"2008","journal-title":"Biomed Chromatogr"},{"key":"R17-8-20210129","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jchromb.2014.03.033","article-title":"Small molecule adduct formation with the components of the mobile phase as a way to analyse valproic acid in human serum with liquid chromatography-tandem mass spectrometry.","volume":"959","author":"Dziadosz","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R18-8-20210129","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/FTD.0000000000000043","article-title":". Comparability and imprecision of 8 frequently used commercially available immunoassays for therapeutic drug monitoring.","volume":"36","author":"Shipkova","year":"2014","journal-title":"Ther Drug Monit"},{"key":"R19-8-20210129","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-4347(92)80189-W","article-title":". Determination of valproic acid by high-performance liquid chromatography with photodiode-array and fluorescence detection.","volume":"576","author":"Liu","year":"1992","journal-title":"J Chromatogr"},{"key":"R20-8-20210129","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/00007691-200206000-00017","article-title":"Evaluation of fluorescence polarization assays for measuring valproic acid, phenytoin, carbamazepine and phenobarbital in serum.","volume":"24","author":"Steijns","year":"2002","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:30:01Z","timestamp":1620952201000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201604000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000256","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]}}}